UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis

Molecular oncology, 2020-08, Vol.14 (8), p.1760-1778

2020

Volltextzugriff (PDF)

Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis

Clinical chemistry (Baltimore, Md.), 2014-06, Vol.60 (6), p.873-885

2014

Volltextzugriff (PDF)

Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors

Molecular cancer therapeutics, 2008-11, Vol.7 (11), p.3642-3653

2008

Volltextzugriff (PDF)

Recombinant Human Hexamer-Dominant IgM Monoclonal Antibody to Ganglioside GM3 for Treatment of Melanoma

Clinical cancer research, 2007-05, Vol.13 (9), p.2745-2750

2007

Volltextzugriff (PDF)

Tumor Necrosis Factor-α and Apoptosis Induction in Melanoma Cells through Histone Modification by 3-Deazaneplanocin A

Journal of investigative dermatology, 2014-05, Vol.134 (5), p.1470-1473

2014

Volltextzugriff (PDF)

Therapeutic Strategies for Human IgM Antibodies Directed at Tumor-Associated Ganglioside Antigens: Discoveries Made During the Morton Era and Future Directions

Critical reviews in oncogenesis, 2016, Vol.21 (1-2), p.75-81

2016

Volltextzugriff (PDF)

Redirected lysis of human melanoma cells by a MCSP/CD3-bispecific BiTE antibody that engages patient-derived T cells

Journal of immunotherapy (1997), 2011-10, Vol.34 (8), p.597-605

2011

Volltextzugriff (PDF)

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

Cancer Immunology, Immunotherapy, 2004-02, Vol.53 (2), p.110-117

2004

Volltextzugriff (PDF)

Human IgM Monoclonal Antibody to Ganglioside GM2 and Complement Suppress Virus Propagation in Ex Vivo Cultures of Lymphocytes from HIV-1 Infected Patients

MICROBIOLOGY and IMMUNOLOGY, 1999, Vol.43(7), pp.723-727

1999

Volltextzugriff (PDF)

Tumor Necrosis Factor-[alpha] and Apoptosis Induction in Melanoma Cells through Histone Modification by 3-Deazaneplanocin A

Journal of investigative dermatology, 2014-05, Vol.134 (5), p.1470

2014

Volltextzugriff (PDF)

Complement-Mediated Anti-HIV-1 Effect Induced by Human IgM Monoclonal Antibody Against Ganglioside GM2

The Journal of immunology (1950), 1999-01, Vol.162 (1), p.533-539

1999

Volltextzugriff (PDF)

Cellular immuno-PCR. Detection of a carbohydrate tumor marker

The American journal of pathology, 1998-06, Vol.152 (6), p.1427-1432

1998

Volltextzugriff (PDF)

Ganglioside GM3:GD3 ratio as an index for the management of melanoma

Cancer, 1991-06, Vol.67 (12), p.3029-3035

1991

Volltextzugriff (PDF)

A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A

Cancer Immunology Immunotherapy, 1993-09, Vol.37 (5), p.316-322

1993

Volltextzugriff (PDF)

Recognition of an epitope of a breast cancer antigen by human antibody

Breast cancer research and treatment, 1999-02, Vol.53 (3), p.279-290

1999

Volltextzugriff (PDF)

Aberrant Expression of Gangliosides in Human Renal Cell Carcinomas

The Journal of urology, 1993-12, Vol.150 (6), p.2013-2018

1993

Volltextzugriff (PDF)

An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy

Cancer research (Chicago, Ill.), 1989-07, Vol.49 (14), p.3891-3897

1989

Volltextzugriff (PDF)

Immunogenicity of melanoma‐associated gangliosides in cancer patients

International journal of cancer, 1985-05, Vol.35 (5), p.607-612

1985

Volltextzugriff (PDF)

Recognition of gp43 Tumor-Associated Antigen Peptide by both HLA-A2 Restricted CTL Lines and Antibodies from Melanoma Patients

Cellular immunology, 1997-06, Vol.178 (2), p.162-171

1997

Volltextzugriff (PDF)

Production and characterization of a murine/human chimeric anti-idiotype antibody that mimics ganglioside

Cancer research (Baltimore), 1992-04, Vol.52 (7), p.1681-1686

1992

Volltextzugriff (PDF)

Anti-Tyrosinase-Related Protein-2 Immune Response in Vitiligo Patients and Melanoma Patients Receiving Active-Specific Immunotherapy

Journal of investigative dermatology, 1998-12, Vol.111 (6), p.1034-1039

1998

Volltextzugriff (PDF)

IgM Anti-Ganglioside Antibodies Induced by Melanoma Cell Vaccine Correlate with Survival of Melanoma Patients

Journal of investigative dermatology, 1999-02, Vol.112 (2), p.205-209

1999

Volltextzugriff (PDF)

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine

Annals of surgery, 1992-10, Vol.216 (4), p.463-482

1992

Volltextzugriff (PDF)

Ganglioside GM2 on the K562 cell line is recognized as a target structure by human natural killer cells

International journal of cancer, 1987-07, Vol.40 (1), p.12-17

1987

Volltextzugriff (PDF)

A membrane antigen common to human cancer and fetal brain tissues

Cancer research (Chicago, Ill.), 1976-09, Vol.36 (9 PT 2), p.3510-3517

1976

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(110)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis

Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis

Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors

Recombinant Human Hexamer-Dominant IgM Monoclonal Antibody to Ganglioside GM3 for Treatment of Melanoma

Tumor Necrosis Factor-α and Apoptosis Induction in Melanoma Cells through Histone Modification by 3-Deazaneplanocin A

Therapeutic Strategies for Human IgM Antibodies Directed at Tumor-Associated Ganglioside Antigens: Discoveries Made During the Morton Era and Future Directions

Redirected lysis of human melanoma cells by a MCSP/CD3-bispecific BiTE antibody that engages patient-derived T cells

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

Human IgM Monoclonal Antibody to Ganglioside GM2 and Complement Suppress Virus Propagation in Ex Vivo Cultures of Lymphocytes from HIV-1 Infected Patients

Tumor Necrosis Factor-[alpha] and Apoptosis Induction in Melanoma Cells through Histone Modification by 3-Deazaneplanocin A

Complement-Mediated Anti-HIV-1 Effect Induced by Human IgM Monoclonal Antibody Against Ganglioside GM2

Cellular immuno-PCR. Detection of a carbohydrate tumor marker

Ganglioside GM3:GD3 ratio as an index for the management of melanoma

A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A

Recognition of an epitope of a breast cancer antigen by human antibody

Aberrant Expression of Gangliosides in Human Renal Cell Carcinomas

An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy

Immunogenicity of melanoma‐associated gangliosides in cancer patients

Recognition of gp43 Tumor-Associated Antigen Peptide by both HLA-A2 Restricted CTL Lines and Antibodies from Melanoma Patients

Production and characterization of a murine/human chimeric anti-idiotype antibody that mimics ganglioside

Anti-Tyrosinase-Related Protein-2 Immune Response in Vitiligo Patients and Melanoma Patients Receiving Active-Specific Immunotherapy

IgM Anti-Ganglioside Antibodies Induced by Melanoma Cell Vaccine Correlate with Survival of Melanoma Patients

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine

Ganglioside GM2 on the K562 cell line is recognized as a target structure by human natural killer cells

A membrane antigen common to human cancer and fetal brain tissues

Suchergebnisse filtern